article thumbnail

Bone scans may be viable for diagnosing calciphylaxis

AuntMinnie

Technetium-99m (Tc-99m) methyl diphosphonate (MDP) bone scans are a potentially viable noninvasive option for diagnosing calciphylaxis, according to a team at the University of Massachusetts in Worcester, MA. The team assessed the potential diagnostic utility of bone scans in calciphylaxis based on a review of the literature.

Bone Scan 297
article thumbnail

Italian research team shows the way on sustainability

AuntMinnie

"Whole-body MRI is emerging as a superior tool for assessing bone marrow and monitoring therapy response in advanced breast cancer. It can detect progressive disease in cases missed by other modalities, demonstrating its potential to guide treatment decisions effectively," they noted. DL2 had the shortest mean scan time (0.27 0.04

Bone Scan 130
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

SPECT/CT improves management of Pluvicto patients

AuntMinnie

Yet whether SPECT/CT can be used to determine disease progression or response has yet to be delineated, they noted. To that end, the group assessed the impact of SPECT/CT imaging on 122 patients who had received a minimum of two cycles of Pluvicto and had post-treatment scans after each cycle.

article thumbnail

PET tracer shows promise in prostate cancer patients

AuntMinnie

Moreover, the approach could help detect disease that other effective prostate cancer PET radiotracers may miss, said Heying Duan, MD, a nuclear medicine research scientist at Stanford University, during a November 26 scientific session. Patients were eligible if they were older than 18 and had rising blood levels of PSA ( ≥ 0.2

article thumbnail

PSMA-PET superior to MRI in phase II prostate cancer trial

AuntMinnie

The primary outcome was the correct identification of the prostate cancer tumor stage, which is crucial for surgeons to determine the extent of the disease -- whether it has spread beyond the prostate gland, for instance. Out of 150 men who participated, 134 ultimately underwent radical prostatectomies (the mean age was 62 years old).

MRI 264
article thumbnail

PSMA-PET tracer performs well in clinical trial

AuntMinnie

PET/CT imaging with a new gallium-68-based prostate cancer radiotracer shows promise for detecting recurrent metastatic disease, according to a study published February 20 in the Journal of Nuclear Medicine. The finding is from a phase I/II clinical trial in the U.S.

Clinic 130
article thumbnail

For Some Prostate Cancer Patients, PSMA PET May Be Better for Initial Staging of Disease

UCSF Biomedical Imaging

An article in the Journal of Nuclear Medicine reports findings of a multi-center retrospective study that compares bone scan with PSMA PET for initial staging of prostate cancer.